Report a side effect Contact Us
  • Who We Are
    Who We Are
    EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
    • Overview
    • Vision, Mission & Values
    • Our History
    • Chairman Message
    • News and Media
      • Press Releases
      • Media Library
    • Sustainability & CSR
  • Manufacturing Facilities
    Manufacturing Facilities
    EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.


    • Overview
    • Factory 1
    • Factory 2
    • Factory 3
    • Eiaco Factory
    • Eipico Plastic Factory
    • Industry Expansion
  • Science & Medicine
    Science & Medicine
    EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
    • Products
    • Products (Alphabetical)
    • R&D and Quality
    • Global Accreditation
    • Regulatory Affairs
  • Global
    Global
    EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
    • Overview
    • Our Export History
    • Eipico Destination
  • Investor Relations
    Investor Relations
    • Investor Relations
    • Annual Reports
  • EIPICO 3
    EIPICO 3
    The First Modular Biological and Biosimilar Facility in Egypt
    • EIPICO 3 (Biologicals & Biosimilars)
 EIPICO to begin producing of “ Epifluovir “ – favipiravir- for covid-19 patients and manufacturing ” Remicovir “ - remdesivir soon. 
 
 
Dr. Ahmed Kelani - Chairman and Managing Director of EIPICO Pharmaceutical Industries Company, said that the company – today - received an approval from the Ministry of Health to manufacture ” Remicovir “ - remdesivir - for the treatment of Corona Virus- in the first week of August and to be supplied by the company- in the second half of August.

Dr. Ahmed Kelani - during a telephone interference with TV program " Al Hekaya " broadcasting through the satellite "MBC Egypt" - on Monday evening- added that the company has produced the Japanese drug - known internationally as "Avigan". ( under the name of “ Epifluovir” ).

The product already is in the company stores and waiting for MOH instructions to provide it to hospitals at a subsidized price.

Dr. Kelani pointed out that the company has provided large quantities of medicines used according to Ministry of Health Protocol for the treatment of Corona Virus. He Also pointing out that EIPICO had suppled hospitals with large quantities of the drug used in the treatment of "C virus".

He continued that: the company seeks to reach high quality of medicines, transferring international technology, and manufacturing the raw material in Egypt, instead of importing it.
 

July 28nd, 2020







WE ARE EIPICO

EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million, currently raised to EGP 1500 Million.

Quick Links

  • EIPICO 3
  • News
  • Products
  • Global accreditation
  • Global
  • Investor relations

Contact Us

EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.

Telephone : +20554499199
Fax : +20554499306

eipico@eipico.com.eg

Back to top
Powered by EIPICO Team
     Visitors Count : 1337793